Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Everolimus”

877 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 877 results

Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Testing effectiveness (Phase 2)Study completedNCT02258451
What this trial is testing

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Bayer 283
Post-approval studies (Phase 4)Study completedNCT00697372
What this trial is testing

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Who this might be right for
Coronary Artery DiseaseCoronary Stenosis
Catholic University of the Sacred Heart 150
Testing effectiveness (Phase 2)Study completedNCT02333565
What this trial is testing

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

Who this might be right for
Recurrent MeningiomasResistant Meningiomas
Assistance Publique Hopitaux De Marseille 20
Testing effectiveness (Phase 2)Ended earlyNCT00727207
What this trial is testing

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Who this might be right for
Lymphoma
Technical University of Munich 35
Large-scale testing (Phase 3)Study completedNCT01626222
What this trial is testing

4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)Study completedNCT02387099
What this trial is testing

Dose EScalation Induction of EvERolimus

Who this might be right for
Breast CancerHormone Receptor Positive Tumor
GBG Forschungs GmbH 156
Testing effectiveness (Phase 2)UnknownNCT01088893
What this trial is testing

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Who this might be right for
Breast Neoplasms
Organisation for Oncology and Translational Research 50
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Early research (Phase 1)Ended earlyNCT01508104
What this trial is testing

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
University of Cincinnati 19
Early research (Phase 1)UnknownNCT00544999
What this trial is testing

Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Institut de Recherche Clinique sur les Cancers et le Sang 21
Testing effectiveness (Phase 2)UnknownNCT02294006
What this trial is testing

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs

Who this might be right for
Well Differentiated Pancreatic Endocrine Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Early research (Phase 1)Study completedNCT01430572
What this trial is testing

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

Who this might be right for
Advanced CancersSolid Tumors
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT02049957
What this trial is testing

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131
Post-approval studies (Phase 4)Study completedNCT01106534
What this trial is testing

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Who this might be right for
Chronic Total Occlusion of Coronary ArteryVascular DiseaseMyocardial Ischemia+4 more
Abbott Medical Devices 870
Post-approval studies (Phase 4)UnknownNCT01093300
What this trial is testing

Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

Who this might be right for
In-stent Restenosis Lesion
Seoul National University Hospital 264
Large-scale testing (Phase 3)Ended earlyNCT04063865
What this trial is testing

Everolimus Monotherapy as Immunosuppression After Liver Transplant

Who this might be right for
Kidney Failure
Indiana University 14
Post-approval studies (Phase 4)Study completedNCT01589978
What this trial is testing

PROMUS Element Plus US Post-Approval Study

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 2,681
Load More Results